Featured Research

from universities, journals, and other organizations

Recent advances in medicine lead to better health for children with juvenile arthritis

Date:
October 27, 2013
Source:
American College of Rheumatology (ACR)
Summary:
There has been a progressive decline in the levels of disease activity and disability among children with juvenile idiopathic arthritis over the past 25 years, according to new research. This research confirms the notion that recent advances in the management of the disease have led to a substantial improvement in health outcomes for children living with it.

There has been a progressive decline in the levels of disease activity and disability among children with juvenile idiopathic arthritis over the past 25 years, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. This research confirms the notion that recent advances in the management of the disease have led to a substantial improvement in health outcomes for children living with it.

There are several types of juvenile idiopathic arthritis, (commonly called JIA or juvenile rheumatoid arthritis) all involving chronic (long-term) joint inflammation. This inflammation begins before patients reach the age of 16, may involve one or many joints, and can cause other symptoms such as fevers, rash and/or eye inflammation. Systemic onset JIA is a subset of JIA that affects about 10 percent of children with arthritis. It begins with recurrent fevers that can be 103° F or higher, often accompanied by a pink rash that comes and goes. Systemic onset JIA may cause inflammation of the internal organs as well as the joints, though joint swelling may not appear until months or even years after the symptoms begin.

Over the last three decades there have been important advances in the management of JIA, which include the introduction of methotrexate as a potential early treatment, the widespread use of intra- articular corticosteroid injections, and -- more recently -- the availability of biologic response modifiers (commonly called biologics). Although this treatment progress has led to a marked improvement in the outlook of children with JIA, the impact of these newer treatments is still poorly documented.

Researchers from the University of Geneva in Geneva, Italy recently reviewed the medical records of 1,079 children who were treated for JIA between January 1987 and March 2012 to determine if there were any noticeable changes in disease activity and physical disability over this period of time.

Throughout the study period, physician -- and parent/patient-centered outcomes were systematically assessed. The researchers leveraged this long term data collection to investigate how changes in treatment over that time period impacted these outcomes.

Measures of disease activity included the physician's and parent's global ratings, the parent's pain rating, and the count of joints with swelling, tenderness or pain.

Measures of disability included the number of joints with limited range of motion and a questionnaire that assessed the ability of the child to perform the physical functional activities and the activities of daily living (the Childhood Health Assessment Questionnaire, CHAQ before March 2007 and the Juvenile Arthritis Functionality Scale, JAFS after that date). To enable comparison of functional ability evaluations, both CHAQ and JAFS scores were converted to a 0-10 scale (0=best; 10=worst). Parent's global and pain ratings as well as functional ability assessment were not available for visits made prior to 1995 because prior to 1195, these assessments were made on scales not comparable

Dr. Ravelli's team reviewed medical records from 6,502 visits in four different time periods: 1) 1987 to 1996; 2) 1996-2000; 3) 2001-2005; and 4) 2006-2012. In all areas reviewed, the researchers noted marked improvements over each successive time period.

"The observation of a progressive decline in the levels of disease activity and physical disability in children with JIA means that pediatric rheumatologists may be more optimistic to children and their parents about disease prognosis and may also reassure them that the child is much less likely to develop damage to joints and impairment in physical function," explains Angelo Ravelli, MD; associate professor of pediatrics; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova; and lead investigator in the study. "The next step is to compare this data with that obtained in the next two to five years, when the impact of the newer biologic medications (namely Tocilizumab (Actemra®), canakinumab (Ilaris®) and rilonacept (Arcalyst®)) will be noted particularly in the care of systemic JIA, which is one of the most severe forms of JIA. In the perspective of an improvement of clinical research methodology, this study demonstrates the importance of regular quantitative assessment of disease state through the use of standardized clinical measures to document in a reliable manner the impact of emerging therapeutic strategies on disease prognosis."


Story Source:

The above story is based on materials provided by American College of Rheumatology (ACR). Note: Materials may be edited for content and length.


Cite This Page:

American College of Rheumatology (ACR). "Recent advances in medicine lead to better health for children with juvenile arthritis." ScienceDaily. ScienceDaily, 27 October 2013. <www.sciencedaily.com/releases/2013/10/131027123149.htm>.
American College of Rheumatology (ACR). (2013, October 27). Recent advances in medicine lead to better health for children with juvenile arthritis. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2013/10/131027123149.htm
American College of Rheumatology (ACR). "Recent advances in medicine lead to better health for children with juvenile arthritis." ScienceDaily. www.sciencedaily.com/releases/2013/10/131027123149.htm (accessed August 20, 2014).

Share This




More Health & Medicine News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Raw: World's Oldest Man Lives in Japan

Raw: World's Oldest Man Lives in Japan

AP (Aug. 20, 2014) — A 111-year-old Japanese was certified as the world's oldest man by Guinness World Records on Wednesday. Sakari Momoi, a native of Fukushima in northern Japan, was given a certificate at a hospital in Tokyo. (Aug. 20) Video provided by AP
Powered by NewsLook.com
Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) — Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com
101-Year-Old Working Man Has All The Advice You Need

101-Year-Old Working Man Has All The Advice You Need

Newsy (Aug. 19, 2014) — Herman Goldman has worked at the same lighting store for almost 75 years. Find out his secrets to a happy, productive life. Video provided by Newsy
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) — Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins